Biotech firm Cyprotex hopes to
break even this year as it targets further expansion in the United States and
Japan. The Macclesfield company, whose technology helps pharmaceutical firms test
the effectiveness of drugs under development, secured its first customer in Japan
last year and won a contract in the US.
Manchester Evening News